ARK Investment Management LLC
Position in CNTN — Canton Strategic Holdings, Inc.
CIK 1697748
ST. PETERSBURG, FL
Position in CNTN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,314,285
-$1,768,639 QoQ
Shares Held
3,657,548
-1.0% QoQ
Ownership
4.59%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1
of 68 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CNTN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARK Investment Management LLC holds $2,096,518,225 across 18 Biotechnology names. CNTN ranks #13 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
9,460,939 | $515,999,613 | |
| 2 | TWST |
Twist Bioscience Corp
|
4,549,803 | $468,083,732 | |
| 3 | BEAM |
Beam Therapeutics Inc.
|
10,234,862 | $351,260,463 | |
| 4 | NTLA |
Intellia Therapeutics, Inc.
|
16,875,684 | $285,536,573 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
41,337,632 | $151,709,109 | |
| 6 | ABSI |
Absci Corp
|
12,925,271 | $149,803,890 | |
| 7 | NRIX |
Nurix Therapeutics, Inc.
|
1,793,196 | $43,502,934 | |
| 8 | PRME |
Prime Medicine, Inc.
|
8,348,746 | $30,806,872 |
All Filings in CNTN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,314,285 | 3,657,548 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,082,924 | 3,695,084 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $9,853,659 | 3,252,033 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||